Saad Ullah
⬤ Hims & Hers Health Inc. (HIMS) shares dropped to around $27 in recent trading, inching closer to the crucial $25 support zone that's caught traders' attention. The stock has been stuck in a steady downtrend through early 2026, trading well below its previous highs with selling pressure showing no signs of letting up.
⬤ The chart tells a pretty clear story – HIMS broke through its main moving averages and hasn't looked back. After hitting a peak near $60, the stock fell into a grinding correction marked by consistent lower highs and lower lows. Over the past several months, price action has compressed steadily toward that $25 support band, an area that previously acted as a floor during earlier consolidation phases.
⬤ Trading volume during the decline points to ongoing selling rather than one big washout moment. The stock's failure to reclaim either the 50-day or longer-term moving averages keeps the downside risk front and center. Every bounce attempt has been met with fresh waves of selling. Technically speaking, the $25 zone stands out as a historically important demand area – making it a level worth watching closely as the stock approaches it again.
⬤ This move matters for the broader digital health sector too. How HIMS behaves around this support zone could signal whether the recent slide is finally running out of steam or if there's more pain ahead. If the stock holds firm around $25, it might slow the bleeding. But a clean break below that level would likely confirm the bearish trend and force traders to reset their expectations for where this thing bottoms out.
Saad Ullah
